GRACE MATTHEWS INSIGHTS

Winter 2024 Newsletter

Click the image to download the latest edition of Grace Matthews Insights

Is Inventory Destocking in the Rear View Mirror?

As the new year continues to unfold, we are embracing the growing sense of optimism for an uptick in M&A activity for manufacturers, distributors, and service providers in the broader chemicals & materials science value chain in 2024. While 2023 was a robust, near-record year for Grace Matthews, we recognize this was an anomaly relative to industry trends, as deal volume in the chemicals & materials science industry experienced its second consecutive year-over-year decline and was down by almost one-third from the peak of 2021.1 Many factors (rising interest rates, inflationary pressures, and pricing increases, to name a few) contributed to a challenging 2023 M&A environment, but one phenomenon touched nearly every company we worked with or spoke to: inventory destocking and its negative impact on demand. As we sit here today more than halfway through the first quarter, we are taking this opportunity to examine, is inventory destocking behind us, and does that mean the industry is entering a period of “normalized demand”? If so, will the potential end of destocking serve as a catalyst for volume and revenue growth and, subsequently, increasing M&A activity in 2024?

If you rewound to the start of 2023, the very concept of inventory destocking would have seemed counterintuitive. At that time, the chemicals & materials science industry was still navigating lingering effects of sequential, compounding shocks, beginning with COVID-19 shutdowns throughout 2020 into the Texas freeze of early 2021 and transitioning into freight and supply chain issues that lingered throughout 2022. A common point of emphasis was supply chain security, which often meant carrying elevated levels of inventory. From manufacturers’ ability to secure key raw materials to distributors carrying select finished goods to service providers capable of avoiding disruptions for their customers, if you had product in 2021-2022, you were able to generate profits (and, in many cases, command a premium). However, as 2023 unfolded and supply chain issues eased, inventory management became a new strategic emphasis. Improved working capital management, particularly relating to inventory levels, was a common organizational priority; for example, we saw compensation plans and bonus structures place more emphasis on reducing working capital and improving free cash flow, which incentivized everyone from purchasing agents to operations managers to drive down inventory levels. In normal times, working capital management is often an M&A arbitrage opportunity, as PE-backed and public companies may look at working capital levels differently than entrepreneurs, who may not be as concerned with the cash impact of higher working capital.

Throughout 2023, as the ripple effect of destocking began to work its way through the value chain, volatile demand patterns impacted the broader industry. Few companies escaped delayed or canceled orders, uncertain guidance from top customers, and prolonged and often unexpected demand weakness relative to recent years. For most, visibility into near-term performance, which in recent years had effectively already gone from navigating a sunny road to driving in a thunderstorm, was now hindered even further (think driving through a snowstorm in the mountains). Companies looked for clues from customers into demand patterns, and these customers could often only point to their own end users as the reason for delayed orders or a downward trend in volumes as the impact worked its way through the value chain.

Clearer Skies Appear on the Horizon

Fortunately, the fog of inventory destocking seems to be clearing, as public commentary notes that clearer skies are on the horizon (perhaps even sunny, though senior managers adept at managing expectations will likely never offer this forecast). Some public executives, such as Gilles Andrier, CEO of Givaudan, suggest that the inventory destocking of 2023 was simply the counter to the upstocking of 2021.  “[The] substantial upstocking in ’21, which was essentially consequent to issues around […] the supply chain […] essentially turned out to be a destocking in ’23,” Andrier noted in a January 2024 earnings call. He concludes that Givaudan expects “[…] a more normalized growth, but with no element of going back to higher inventory levels.” Others, such as Martha Gilchrist Moore, Chief Economist of the American Chemistry Council, agree that destocking is diminishing in pockets, and we now enter a waiting period for normalized demand. Moore noted in November 2023, “We think [destocking] has pretty much played out […] we are starting to see some green shoots of firming demand in certain areas.” 

In retrospect, inventory destocking may have simply been the industry’s natural and rational reaction to drive balance sheets to more efficient levels following a one-time rapid rise in inventories from a couple years’ prior. In our Fall 2023 newsletter, we examined quarterly inventory levels over the past 5+ years for ~80 publicly traded companies, and we re-ran this analysis with data available as of February 2024. The data highlights the substantial downtick in inventory levels, though whether we have reached the full leveling off point or are continuing to see decreased inventories will be determined as Q4-23 and Q1-24 results become available. And while destocking’s impact may become negligible in 2024, with the exact timing depending on a company’s geography and markets served, we would expect that companies start to experience more normalized demand and order patterns as this happens (or, at least, as close to “normal” as possible given the dynamic state of the world). Interestingly, early signs from senior executives suggest we may, in fact, be entering into the “new normal.”

Notable Management Commentary

“However, as we finish 2023, we did see additional channel inventory destocking within many of our industrial base businesses as well as continued weak demand in China […] We have already noted that we see a continuation of similar volume trends into the first quarter […] but we are encouraged that we see signs of market stabilization, bottoming of customer inventories and a pickup in orders in the month of January that support a view of recovering sales and earnings through 2024.”

—Edward Breen (Executive Chairman & CEO of DuPont); Q4-23 Earnings Call (Feb. 6, 2024)

“The past year represented a challenging and dynamic year for Carlisle. The first half of the year was impacted by continued destocking in our markets and the related challenges driven by supply chain constraints for many building products, including ours in 2022. Despite those first half challenges, markets began a return to a more normalized order pattern beginning in the third quarter of 2023. This resulted in the second half of 2023 that was marked by increasingly positive momentum […] We are very pleased to be entering 2024 on a positive note with destocking behind us and with positive momentum.”

—D. Christian Koch (Chairman, President & CEO of Carlisle Companies); Q4-23 Earnings Call (Feb. 6, 2024)

“As we noted in our earnings release, our 2 largest end markets of packaging and consumer benefited from the slowed pace of destocking during the fourth quarter […] This, along with the order trends to start the year and insights from our customers, gives us confidence that destocking has largely come to an end in these areas and that orders are more of a reflection of underlying demand.”

—Dr. Ashish Khandpur (President, CEO & Director of Avient Corporation); Q4-23 Earnings (Feb. 14, 2024) 

“Our first quarter guidance reflects the trend of volume declines and related impacts to EBITDA that we’ve seen over the last 3 quarters. The destocking trend is expected to level off and start inflecting after the first quarter.”

—Mark Douglas (President, CEO & Director of FMC Corporation); Q4-23 Earnings Call (Feb. 6, 2024)

Improved Visibility Will Contribute to a Better Outlook for M&A

We referenced earlier that inventory destocking’s direct effects (reduced demand) and indirect effects (limited visibility into near-term performance) were likely contributors to reduced chemicals & materials science M&A activity in 2023. Poor visibility into customer order patterns coupled with an inability to create reliable projections not only made running a business difficult but also made driving M&A transactions forward a challenge. When buying a business, buyers are acquiring future cash flows, and they typically use last-twelve-months (LTM) performance as a proxy for this; with LTM performance often unexpectedly volatile in 2023 due to the aforementioned dynamics, buyers struggled with what they were underwriting in a deal, which created obstacles in terms of reaching a conclusion of a deal that worked for both buyer and seller. 

Grace Matthews Inventory Index

To gauge inventory levels across the industry, the chart below shows quarterly reported inventory levels for ~80 publicly traded chemicals & materials science companies in the Grace Matthews Index. The chart is indexed to 1.0 in Q1-18, does not distinguish between volumes and pricing, and is not adjusted for annual inflation. 

*Note: Q4-23 period includes data on ~50 companies, representing only those that have reported Q4-23 earnings, including balance sheet metrics, as of the date of this publication. 
Source: Capital IQ, Company Filings, Grace Matthews analysis. 

If destocking gradually fades away this year, we would expect companies who have retained key customer relationships and proximity to their top accounts should have improved confidence in the near- and medium-term performance outlook. This, in turn, should increase the probability of forecast execution, which is especially crucial for companies out to market during the 3-6 month window during which financials are heavily scrutinized. Better visibility into performance can also lead to more informed decisions regarding when to start a potential M&A process. All else equal, sellers would prefer to see LTM performance improving during the window they’re talking with buyers. We often find ourselves talking to owners about when the best time may be to begin discussions with buyers, though we acknowledge the timing is never going to be perfect. On top of the importance of preparing thoughtful marketing materials and getting ahead of the diligence process before engaging with buyers, we strongly recommend sellers incorporate the near- and medium-term performance outlook into their decision-making process. Often, a granular quantitative explanation of any destocking impact can be key to driving and holding value in a sale process—we excel at helping in this analysis.

No single factor will drive an industry-wide M&A trend. However, if the negative demand impacts and increased uncertainty that we saw from inventory destocking fade away in 2024, we view this as a more favorable M&A environment and, frankly, an environment that promotes opportunities for sustainable organic growth. Given the budding optimism we are seeing and the perceived willingness of both buyers and sellers to engage in transactions, we believe this bodes well for the near-term outlook in terms of both M&A and demand normalization in the broader chemicals & materials science value chain. 

Grace Matthews Chemicals & Materials Index (EV / EBITDA Multiples)

The Grace Matthews Chemical & Materials Index tracks the Enterprise Value / EBITDA ratios (“EV / EBITDA multiples” or “EBITDA multiples”) of ~100 publicly traded chemicals & materials companies that span multiple sub-sectors and geographies. The Index aggregates the latest reported financial data and stock prices, and tracks valuation trends and operating metrics across different industry sectors. Index averages are equally weighted, as opposed to weighting by market capitalization.

Source: Capital IQ & Grace Matthews analysis.

1 Source: Capital IQ, Company Filings, Grace Matthews analysis.

Select Chemicals and Materials Science Transactions

Closed Date Acquirer / Target Target Description Enterprise Value (EV) EV / Sales EV / EBITDA

Transaction values in $US millions

Pending
Koch Industries / Iowa Fertilizer
Producer of nitrogen fertilizer and diesel exhaust fluid
$3,600
Pending
Henkel / Seal for Life Industries
Manufacturer of protective coating and sealing solutions
Pending
INEOS / LyondellBasell (Ethylene Oxide & Derivatives Business)
Producer of ethylene oxide and derivatives
$700
Pending
Kingswood Capital Management / Corbion (Emulsifiers Business)
Emulsifiers for the food and beverage industry
$362
Pending
Italmatch Chemicals / Alcolina
Manufacturer of water treatment products for bioethanol, sugar production, and industrial applications
Pending
Brenntag / Solventis
Distributor of glycols and solvents
Pending
Clariant / IFF (Lucas Meyer Cosmetics Business)
Ingredients provider for the cosmetics and personal care industry
$810
8.1x
16.3x
Feb-24
ADM / Fuerst Day Lawson
Manufacturer of taste and nutrition ingredient solutions
Feb-24
Somafina / UST Corporation
Contract manufacturer of dietary supplements, including vitamins, minerals, and nutritional supplements
Feb-24
Sterling Specialty Chemicals / Kemira (Oil & Gas Business)
Provider of treatment chemicals for oil sands tailings, EOR, and shale oil & gas
$280
Jan-24
Phillips Carbon Black / Aquapharm Chemical
Producer of specialty chemicals primarily for water treatment and oil & gas applications
$456
1.9x
9.1x
Jan-24
Novozymes / Chr. Hansen
Ingredients provider for the food and agricultural industries
$12,495
9.4x
28.1x
Jan-24
Kano Laboratories / Synco Chemical Corporation (Super Lube and Synco Brands)
Manufacturer of synthetic food grade greases and lubricants
Jan-24
Bamberger Polymers / Amco Polymers
Distributor of resins and compounding solutions
Jan-24
NewMarket / American Pacific
Producer of specialty chemicals for military defense applications
$700
Jan-24
IMCD / Valuetree Ingredients (70% Stake)
Provider of ingredients for the beauty and personal care industry
Jan-24
PQ Corporation / Van Baerle (Specialty Silicate Business)
Manufacturer of high-grade silicates
Jan-24
ALTANA / Silberline Group
Manufacturer of aluminum effect pigments
Jan-24
Shrieve Chemical / TLC Ingredients
Distributor of food ingredients and industrial products
Jan-24
MFG Chemical / Masters Company
Manufacturer of water treatment products
Jan-24
USALCO / Brenntag (Coagulant Business)
Manufacturer of coagulants for the water treatment industry
Jan-24
Black Bay Energy Capital / Merichem (Technologies & Catalyst Business)
Provider of sulfur treating technologies and chemical catalysts
Dec-23
Samyang Group / Verdant Specialty Solutions
Manufacturer of surfactants and specialty chemicals for the personal care and industrial markets
$250
1.2x
Dec-23
IDEX / STC Material Solutions
Manufacturer of technical ceramics
$206
Dec-23
TPG Rise Climate / A-Gas
Gas and chemical distributor and supplier focused on lifecycle management of refrigerant gases
Dec-23
Arkema / Arc Building Products
Manufacturer of tile adhesives, building chemicals, and floor preparation systems
Dec-23
Hidden Harbor Capital Partners / Teckrez
Provider of tackifier resin and acrylic monomer solutions
Nov-23
SK Capital / J&K Ingredients
Manufacturer and supplier of food and beverage ingredients
Nov-23
KKR / Chase Corporation
Manufacturer of industrial coatings, tapes, and protective materials
$1,300
3.3x
13.7x
Nov-23
CapVest Partners / Recochem
Distributor and producer of transportation and household fluids
Nov-23
Vivify Specialty Ingredients / Access Ingredients
Distributor of personal care raw materials
Nov-23
The Jordan Company / DuPont (Delrin Resins Business)
Manufacturer of acetal homopolymer for high-load mechanical applications
$1,800
Oct-23
Roquette / Qualicaps
Manufacturer of hard capsules and pharmaceutical related equipment
Oct-23
Integrity Partners Group / West Penetone (Military & Aerospace Business)
Provider of specialty cleaners and degreasers
Oct-23
Fujifilm / Entegris (Electronics Chemicals Business)
Manufactures, formulates, and distributes specialty chemicals and performance materials
$700
Oct-23
SK Capital / Ecopol
Developer and producer of biodegradable films
Scroll to Top